Envestnet Asset Management Inc. Sells 79,123 Shares of BWX Technologies, Inc. $BWXT

Envestnet Asset Management Inc. decreased its stake in shares of BWX Technologies, Inc. (NYSE:BWXT) by 36.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 136,855 shares of the technology company’s stock after selling 79,123 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.15% of BWX Technologies worth $25,232,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in BWXT. Artisan Partners Limited Partnership bought a new stake in shares of BWX Technologies during the second quarter valued at approximately $183,859,000. William Blair Investment Management LLC raised its position in BWX Technologies by 523.2% during the 2nd quarter. William Blair Investment Management LLC now owns 1,517,356 shares of the technology company’s stock valued at $218,590,000 after purchasing an additional 1,273,895 shares in the last quarter. Invesco Ltd. raised its position in BWX Technologies by 139.0% during the 2nd quarter. Invesco Ltd. now owns 1,592,380 shares of the technology company’s stock valued at $229,398,000 after purchasing an additional 926,117 shares in the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of BWX Technologies in the 2nd quarter worth $132,498,000. Finally, Alkeon Capital Management LLC bought a new position in shares of BWX Technologies during the 2nd quarter worth $86,443,000. 94.39% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on BWXT. BNP Paribas Exane began coverage on BWX Technologies in a report on Thursday, January 15th. They issued a “neutral” rating and a $215.00 price objective for the company. Bank of America upped their price target on shares of BWX Technologies from $220.00 to $230.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Wall Street Zen upgraded shares of BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. CJS Securities raised shares of BWX Technologies to a “strong-buy” rating in a report on Friday, December 12th. Finally, Truist Financial set a $205.00 target price on BWX Technologies in a report on Friday, January 9th. Three investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, BWX Technologies has a consensus rating of “Moderate Buy” and an average price target of $199.20.

BWX Technologies Stock Down 0.8%

Shares of BWXT stock opened at $196.99 on Friday. The stock’s fifty day moving average price is $192.20 and its 200 day moving average price is $184.40. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.71 and a quick ratio of 1.62. BWX Technologies, Inc. has a 1-year low of $84.21 and a 1-year high of $220.57. The company has a market cap of $18.01 billion, a price-to-earnings ratio of 59.16, a price-to-earnings-growth ratio of 3.19 and a beta of 0.84.

BWX Technologies Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.